TrialSpark July 2024 exempt equity offering disclosure
Primary Investment02/07/2024
TrialSpark, Inc., commercially rebranded Formation Bio, reported [figure hidden] of equity sold against a [figure hidden] offering in its July 2, 2024 Form D. It reported first sale on May 21, 2024 and 16 investors. This is a dated securities-offering snapshot, not revenue, valuation, cash or lifetime fundraising; the unsold balance is not capital raised.
Type
Primary Investment
Announced
02/07/2024
Amount
Financial data requires access
Asset class
Venture Capital
Reported parties
Formation Bio